Dashboard
Manage Tickers

MASIMASIMO CORP

Nasdaq masimo.com


$ 111.49 $ -2.74 (-2.4 %)    

Friday, 06-Sep-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 111.53
$ 114.84
$ 111.39 x 100
-- x --
$ 110.25 - $ 115.82
$ 75.22 - $ 153.93
315,987
na
5.93B
$ 0.89
$ 74.72
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-29-2024 10-Q
2 05-07-2024 03-30-2024 10-Q
3 02-28-2024 12-30-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-08-2023 07-01-2023 10-Q
6 05-10-2023 04-01-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 10-01-2022 10-Q
9 08-10-2022 07-02-2022 10-Q
10 05-03-2022 04-02-2022 10-Q
11 02-15-2022 01-01-2022 10-K
12 10-26-2021 10-02-2021 10-Q
13 07-27-2021 07-03-2021 10-Q
14 04-27-2021 04-03-2021 10-Q
15 02-23-2021 01-02-2021 10-K
16 10-27-2020 09-26-2020 10-Q
17 07-28-2020 06-27-2020 10-Q
18 04-28-2020 03-28-2020 10-Q
19 02-19-2020 12-28-2019 10-K
20 10-30-2019 09-28-2019 10-Q
21 07-31-2019 06-29-2019 10-Q
22 05-06-2019 03-30-2019 10-Q
23 02-26-2019 12-29-2018 10-K
24 10-31-2018 09-29-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 02-28-2018 12-30-2017 10-K
28 10-31-2017 09-30-2017 10-Q
29 08-02-2017 07-01-2017 10-Q
30 05-04-2017 04-01-2017 10-Q
31 02-15-2017 12-31-2016 10-K
32 11-02-2016 10-01-2016 10-Q
33 08-03-2016 07-02-2016 10-Q
34 05-04-2016 04-02-2016 10-Q
35 02-24-2016 01-02-2016 10-K
36 11-06-2015 10-03-2015 10-Q
37 08-04-2015 07-04-2015 10-Q
38 05-06-2015 04-04-2015 10-Q
39 02-17-2015 01-03-2015 10-K
40 10-29-2014 09-27-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

masimo-ceo-shared-confidential-information-with-investor-ahead-of-public-release-court-filing-shows---cnbc
'Masimo CEO Shared Confidential Informatio...
09/06/2024 19:58:19

https://www.cnbc.com/2024/09/06/masimo-ceo-shared-confidential-information-ahead-of-release-documents.htmlMasimo CEO Joe Kiani ...

masimo-collaborates-with-march-of-dimes-to-assist-nicu-parents-in-transitioning-their-babies-from-hospital-to-home
Masimo Collaborates With March Of Dimes To...
08/27/2024 11:16:39

Company to Donate $100,000 of Stork™ Smart Home Baby Monitoring Systems and Take Part in a March of Dimes Donation Matching Pro...

masimo-files-revised-definitive-proxy-materials-with-sec-for-upcoming-annual-meeting-of-stockholders-on-september-19-2024
Masimo Files Revised Definitive Proxy Mate...
08/15/2024 13:17:00

Stockholders Of Record As Of August 12, 2024, Are Eligible To Vote

masimos-w1-medical-watch-receives-fda-510k-clearance-for-connectivity-to-themasimo-safetynet-telemonitoring-system
Masimo's W1 Medical Watch Receives FDA 510...
08/12/2024 12:03:22

piper-sandler-maintains-overweight-on-masimo-raises-price-target-to-165
Piper Sandler Maintains Overweight on Masi...
08/07/2024 11:16:43

Piper Sandler analyst Jason Bednar maintains Masimo (NASDAQ:MASI) with a Overweight and raises the price target from $160 to...

5needham-reiterates-hold-on-masimo
5Needham Reiterates Hold on Masimo
08/07/2024 10:34:23

Needham analyst Mike Matson reiterates Masimo (NASDAQ:MASI) with a Hold.

masimo-sees-q3-2024-revenue-495m-515m-vs-493m-estimate-sees-eps-022-027-vs-026-estimate
Masimo Sees Q3 2024 Revenue $495M-$515M Vs...
08/06/2024 20:49:49

masimo-q2-2024-adj-eps-086-beats-076-estimate-sales-49630m-beat-49356m-estimate
Masimo Q2 2024 Adj EPS $0.86 Beats $0.76 E...
08/06/2024 20:27:59

Masimo (NASDAQ:MASI) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.76 by 13.16...

masimo-commenced-litigation-against-politan-capital-management-in-federal-court-in-california-seeking-to-require-politan-to-correct-material-misstatements-and-omissions-in-politans-proxy-materials
Masimo Commenced Litigation Against Polita...
07/16/2024 09:24:42

proxy-advisor-iss-says-masimo-change-is-absolutely-necessary-in-brutal-report-says-shareholders-should-vote-for-activist-politan-capital-managements-board-nominees-bill-jellison-and-darlene-solomon
Proxy Advisor ISS Says Masimo Change Is 'A...
07/15/2024 16:11:28

- Reuters Citing CNBC

masimo-exposes-politans-governance-hypocrisy-says-over-the-past-twelve-months-we-believe-politans-quentin-koffey-has-repeatedly-acted-against-the-best-interests-of-masimo-and-its-stockholders
Masimo Exposes Politan's Governance Hypocr...
07/11/2024 13:12:57

Highlights Quentin Koffey's Actions That Have Flown in the Face of Good GovernanceMasimo Corporation ("Masimo" or t...

whats-going-on-with-health-technology-company-masimo-shares-today
What's Going On With Health Technology Com...
07/09/2024 16:26:22

Masimo reportedly considers an $850 million to $950 million bid for its consumer business amid active joint venture discussions...

needham-reiterates-hold-on-masimo
Needham Reiterates Hold on Masimo
07/09/2024 15:49:02

Needham analyst Mike Matson reiterates Masimo (NASDAQ:MASI) with a Hold.

masimo-preliminary-q2-2024-revenue-expected-to-be-496m
Masimo Preliminary Q2 2024 Revenue Expecte...
07/09/2024 13:06:31

Masimo Corporation (NASDAQ:MASI) today announced preliminary revenue and select financial results for the second quarter ended ...

Core News & Articles
Masimo Receives Non-Binding Term Sheet Fro...
07/08/2024 13:08:25

- Reuters

masimo-announces-sleep-halo-advanced-sleep-analysis-for-the-masimo-w1
Masimo Announces Sleep Halo, Advanced Slee...
07/01/2024 12:06:39

Sleep Halo Sleep Metrics Are Based on Masimo W1's Continuous Pulse Oximetry Measurements and Advanced Halo AI TechnologyMas...

masimo-coo-bilal-muhsin-threatens-resignation-if-ceo-joe-kiani-is-removed
Masimo COO Bilal Muhsin Threatens Resignat...
07/01/2024 10:18:57

On June 26, 2024, Bilal Muhsin, the Chief Operating Officer of Masimo Corporation (the “Company”) sent a letter (the “Muhsin Co...

masimo-and-cleveland-clinic-collaborate-to-improve-hospital-remote-care-including-telecritical-care
Masimo And Cleveland Clinic Collaborate To...
06/27/2024 14:12:50

Masimo (NASDAQ:MASI), a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, ...

masimo-files-investor-presentation-highlighting-strategic-initiatives-to-deliver-robust-growth-and-margin-expansion-politan-is-making-a-bid-for-control-without-paying-a-premium-or-articulating-a-clear-plan-seeking-to-replace-masimo-founder-chairman-and-ceo-joe-kiani-with-politan-nominees
Masimo Files Investor Presentation Highlig...
06/26/2024 14:36:03

Masimo's Strategy Capitalizes on Innovation to Enhance Growth and Create Value for All StockholdersPolitan is Making a Bid ...

masimo-secures-dismissal-of-infringement-lawsuit-filed-by-wrist-sp-biotech
Masimo Secures Dismissal Of Infringement L...
06/24/2024 13:05:58

Knobbe Martens secured another victory for Masimo Corporation (NASDAQ:MASI) with the successful dismissal with prejudice of a p...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION